Announcements Trials

Browse Landscape

Phase

Phase NA 11 Phase 4 6 Phase 2 3 Phase EARLY_PHASE1 1 Phase 3 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 161 Neoplasms 95 Prostatic Neoplasms 86 Glioblastoma 76 Multiple Myeloma 66 Pancreatic Neoplasms 64 Glioma 62 Brain Neoplasms 56 Lung Neoplasms 46 Carcinoma, Hepatocellular 45 Melanoma 44 Head and Neck Neoplasms 43 Recurrence 42 Carcinoma, Non-Small-Cell Lung 41 Leukemia, Myeloid, Acute 40 Colorectal Neoplasms 39 Squamous Cell Carcinoma of Head and Neck 35 Ovarian Neoplasms 35 Precursor Cell Lymphoblastic Leukemia-Lymphoma 31 Neoplasm Metastasis 29 Lymphoma, Non-Hodgkin 29 Lymphoma 29 Carcinoma, Renal Cell 28 Polycystic Ovary Syndrome 27 Stomach Neoplasms 24 Hematologic Neoplasms 23 Sarcoma 22 Lymphoma, B-Cell 22 Endometrial Neoplasms 20 Uterine Cervical Neoplasms 19

Interventions

Mirtazapine 1 Citalopram 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × OTHER × Depressive Disorder, Major × Clear all

NCT01725048 2017-03-13

NRR

UNC Lineberger Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed

Depressive Disorder, Major, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡